- Home
- MYGN vs KC Comparison
MYGN vs KC Comparison
Compare MYGN & KC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- KC
- Stock Information
- Founded
- MYGN 1991
- KC 2012
- Country
- MYGN United States
- KC China
- Employees
- MYGN N/A
- KC N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- KC Computer Software: Prepackaged Software
- Sector
- MYGN Health Care
- KC Technology
- Exchange
- MYGN Nasdaq
- KC Nasdaq
- Market Cap
- MYGN 2.0B
- KC 1.9B
- IPO Year
- MYGN 1995
- KC 2020
- Fundamental
- Price
- MYGN $13.69
- KC $8.57
- Analyst Decision
- MYGN Hold
- KC Strong Buy
- Analyst Count
- MYGN 12
- KC 7
- Target Price
- MYGN $23.92
- KC $5.69
- AVG Volume (30 Days)
- MYGN 904.0K
- KC 4.4M
- Earning Date
- MYGN 11-07-2024
- KC 11-19-2024
- Dividend Yield
- MYGN N/A
- KC N/A
- EPS Growth
- MYGN N/A
- KC N/A
- EPS
- MYGN N/A
- KC N/A
- Revenue
- MYGN $823,600,000.00
- KC $1,037,206,927.00
- Revenue This Year
- MYGN $13.82
- KC $9.78
- Revenue Next Year
- MYGN $4.59
- KC $11.12
- P/E Ratio
- MYGN N/A
- KC N/A
- Revenue Growth
- MYGN 12.15
- KC N/A
- 52 Week Low
- MYGN $13.81
- KC $2.02
- 52 Week High
- MYGN $29.30
- KC $9.70
- Technical
- Relative Strength Index (RSI)
- MYGN 26.49
- KC 61.66
- Support Level
- MYGN $13.92
- KC $8.06
- Resistance Level
- MYGN $15.44
- KC $9.67
- Average True Range (ATR)
- MYGN 0.79
- KC 0.52
- MACD
- MYGN 0.03
- KC -0.11
- Stochastic Oscillator
- MYGN 3.06
- KC 62.76
About MYGN Myriad Genetics Inc.
Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the capability to identify the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.
About KC Kingsoft Cloud Holdings Limited
Kingsoft Cloud Holdings Ltd is an independent cloud service provider in China. It provides integrated cloud-based services including cloud computing, storage, and delivery. Its products and services are Safety, database, AI, hybrid cloud and others. Its solutions are medical, government affairs, finance, media, Educate, game, Transportation and Logistics, Audio, and video.